EDGAR Filing Documents for 0001532176-12-000004

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001532176-12-000004

Filing Date

2012-10-24

Accepted

2012-10-24 07:29:40

Documents

Period of Report

2012-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	regn-93012x10q.htm	10-Q	1569914
2	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	regn-ex_311x9302012x10q.htm	EX-31.1	15202
3	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	regn-ex_312x9302012x10q.htm	EX-31.2	16058
4	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	regn-ex_32x9302012x10q.htm	EX-32	6708
	Complete submission text file	0001532176-12-000004.txt		7431002

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	regn-20120930.xml	EX-101.INS	1306011
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	regn-20120930.xsd	EX-101.SCH	30915
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	regn-20120930_cal.xml	EX-101.CAL	73054
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	regn-20120930_def.xml	EX-101.DEF	153430
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	regn-20120930_lab.xml	EX-101.LAB	446602
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	regn-20120930_pre.xml	EX-101.PRE	228568

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)